Results 61 to 70 of about 112,931 (195)

High Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD Alloimmunization

open access: yesFrontiers in Immunology, 2017
Maternal RhD alloimmunization is an inflammatory response against protein antigens in fetal red blood cells (RBC). However, not all women become alloimmunized when exposed to RhD+ fetal RBC.
Juliana Araújo de Carvalho Schettini   +8 more
doaj   +1 more source

The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Red blood cell (RBC) alloimmunization remains a relevant cause of hemolytic disease of the fetus and newborn (HDFN). Although RhD immunization has significantly decreased since the implementation of systematic prophylaxis, it is still the main cause of alloimmunization in pregnancy.
Mar Bennasar, Antoni Borrell
wiley   +1 more source

Fetal RhD genotyping from maternal plasma

open access: yesAnnals of Medicine, 1999
The prenatal diagnosis of fetal rhesus D (RhD) status is useful for the management of RhD-negative women with partners heterozygous for the RHD gene. Conventional methods for prenatal fetal RhD status determination involve invasive procedures such as fetal blood sampling and amniocentesis.
openaire   +2 more sources

Identification of rare blood group donors from biobank data

open access: yesBritish Journal of Haematology, EarlyView.
Safe blood transfusion requires compatibility between recipient antibodies and donor red blood cell antigens, posing challenges for patients with rare blood group phenotypes, particularly those who are alloimmunized. Traditional identification of rare donors relies on targeted screening and labour‐intensive laboratory methods, often limited by ...
Inna Sareneva   +8 more
wiley   +1 more source

Comprehensive prospective investigation of splicing variants in the coding region of RHD: Insights into phenotypic consequences including revision of RHD*weak D type 3

open access: yesBritish Journal of Haematology, EarlyView.
Summary As splicing has been shown to be commonly altered by single nucleotide variants (SNVs) in the RHD gene, resulting in a mild to severe drop in the expression of the D antigen, we sought to identify prospectively those deleterious SNVs that may disrupt splicing. All potential substitutions affecting the coding deoxyribonucleic acid (DNA) sequence
Yann Fichou   +8 more
wiley   +1 more source

Understanding extracellular vesicles in antiaging

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Aging is a multifactorial process marked by gradual cellular dysregulation, regulated by hallmarks, including genomic instability, mitochondrial dysregulation, and chronic inflammation. Extracellular vesicles (EVs), especially exosomes, have emerged as pivotal mediators of cell‐to‐cell communication with potential roles in both ...
Paras Ahmad   +3 more
wiley   +1 more source

Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland

open access: yesBiomedicines, 2023
RH1 incompatibility between mother and fetus can cause hemolytic disease of the fetus and newborn. In Switzerland, fetal RHD genotyping from maternal blood has been recommended from gestational age 18 onwards since the year 2020.
Bernd Schimanski   +11 more
doaj   +1 more source

CHARACTERIZATION OF RHD*D WEAK TYPE 15 PHENOTYPE IN A JAPANESE PREGANT WOMAN – CASE REPORT

open access: yesHematology, Transfusion and Cell Therapy, 2023
Aim: We describe a case of an obstetric patient, asian, whose Red Blood Cells (RBCs) showed a low expression of the RH:1 antigen in the routine tests and the strategies used for the characterization of an unusual RHD variant.
MG Aravechia   +6 more
doaj   +1 more source

A retrospective analysis of the antigen‐negative red blood cell supply conducted at a single centre in China

open access: yesTransfusion Medicine, EarlyView.
Abstract Objective This study aimed to analyse the distribution and demand patterns of antigen‐negative red blood cells (RBCs) in Shandong Province, China (2022–2024), with a focus on ABO blood groups and clinically significant antigens. The research was designed to provide rigorous data for advancing precision transfusion protocols and to establish a ...
Aiping Zhao   +7 more
wiley   +1 more source

Fetal RHD genotyping after bone marrow transplantation

open access: yesTransfusion, 2016
BACKGROUNDFetal RHD genotyping allows targeted diagnostic testing, fetal surveillance, and eventually intrauterine treatment to D‐alloimmunized pregnant women who carry an RHD+ fetus. However, false‐positive and false‐negative results of noninvasive prenatal fetal RHD genotyping have been described due to a variety of causes.
Thurik, Florentine F.   +8 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy